DUVOID Drug Patent Profile
✉ Email this page to a colleague
When do Duvoid patents expire, and when can generic versions of Duvoid launch?
Duvoid is a drug marketed by Chartwell Rx and is included in three NDAs.
The generic ingredient in DUVOID is bethanechol chloride. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Duvoid
A generic version of DUVOID was approved as bethanechol chloride by UPSHER SMITH LABS on June 1st, 2005.
Summary for DUVOID
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 101 |
Patent Applications: | 1,356 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DUVOID at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DUVOID
US Patents and Regulatory Information for DUVOID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Rx | DUVOID | bethanechol chloride | TABLET;ORAL | 086262-001 | Approved Prior to Jan 1, 1982 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Chartwell Rx | DUVOID | bethanechol chloride | TABLET;ORAL | 086263-001 | Approved Prior to Jan 1, 1982 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Chartwell Rx | DUVOID | bethanechol chloride | TABLET;ORAL | 085882-003 | Approved Prior to Jan 1, 1982 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |